Wealthfront Advisers LLC acquired a new stake in shares of Equifax, Inc. (NYSE:EFX - Free Report) during the second quarter, according to its most recent filing with the SEC. The fund acquired 7,540 shares of the credit services provider's stock, valued at approximately $1,197,000.
A number of other institutional investors have also added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in shares of Equifax during the second quarter valued at about $1,491,357,000. State Street Corp lifted its holdings in shares of Equifax by 1.3% in the fourth quarter. State Street Corp now owns 5,056,441 shares of the credit services provider's stock worth $1,097,147,000 after buying an additional 66,289 shares in the last quarter. Soroban Capital Partners LP boosted its position in shares of Equifax by 310.5% in the first quarter. Soroban Capital Partners LP now owns 4,184,569 shares of the credit services provider's stock valued at $753,515,000 after acquiring an additional 3,165,120 shares during the period. Brown Advisory Inc. boosted its position in shares of Equifax by 57.2% in the fourth quarter. Brown Advisory Inc. now owns 2,809,879 shares of the credit services provider's stock valued at $609,693,000 after acquiring an additional 1,022,819 shares during the period. Finally, Bank of America Corp DE grew its stake in Equifax by 36.5% during the first quarter. Bank of America Corp DE now owns 2,107,458 shares of the credit services provider's stock valued at $379,490,000 after acquiring an additional 563,880 shares in the last quarter. Hedge funds and other institutional investors own 96.20% of the company's stock.
Equifax Stock Up 0.3%
EFX stock opened at $192.98 on Friday. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.92. The company's 50 day moving average is $172.16 and its 200 day moving average is $178.12. The stock has a market cap of $22.67 billion, a price-to-earnings ratio of 33.92, a price-to-earnings-growth ratio of 1.54 and a beta of 1.30. Equifax, Inc. has a 1-year low of $150.74 and a 1-year high of $271.84.
Equifax (NYSE:EFX - Get Free Report) last announced its earnings results on Tuesday, July 21st. The credit services provider reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $2.20 by $0.05. Equifax had a net margin of 10.73% and a return on equity of 21.61%. The business had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.70 billion. During the same period last year, the firm posted $2.00 earnings per share. Equifax's quarterly revenue was up 10.6% on a year-over-year basis. Equifax has set its Q3 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.390-8.690 EPS. Sell-side analysts predict that Equifax, Inc. will post 8.57 EPS for the current fiscal year.
Equifax Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Monday, August 31st will be given a dividend of $0.56 per share. The ex-dividend date is Monday, August 31st. This represents a $2.24 annualized dividend and a dividend yield of 1.2%. Equifax's dividend payout ratio (DPR) is 39.37%.
Insider Activity
In other news, CEO Mark W. Begor sold 37,791 shares of Equifax stock in a transaction on Friday, July 24th. The shares were sold at an average price of $172.16, for a total transaction of $6,506,098.56. Following the completion of the sale, the chief executive officer directly owned 271,890 shares of the company's stock, valued at approximately $46,808,582.40. The trade was a 12.20% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.70% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on the stock. Bank of America decreased their target price on shares of Equifax from $250.00 to $225.00 and set a "buy" rating on the stock in a report on Tuesday, May 19th. Needham & Company LLC cut their price target on shares of Equifax from $265.00 to $245.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd. Weiss Ratings upgraded shares of Equifax from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Thursday, August 13th. BNP Paribas Exane decreased their price target on shares of Equifax from $195.00 to $185.00 and set a "neutral" rating on the stock in a report on Thursday, June 18th. Finally, BMO Capital Markets lowered their price objective on Equifax from $195.00 to $179.00 and set a "market perform" rating on the stock in a research report on Monday, July 13th. Fourteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, Equifax presently has a consensus rating of "Moderate Buy" and a consensus target price of $216.89.
Get Our Latest Stock Report on EFX
Equifax Profile
(
Free Report)
Equifax Inc NYSE: EFX is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.
The company's offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.
Featured Stories
Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax, Inc. (NYSE:EFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report